Abbey A, et al. DAVIO 2: Year 1 results from a phase 2, multicenter, non-inferiority trial of EYP-1901 (vorolanib intravitreal insert) versus aflibercept for previously-treated wet age-related ...

Further information Decision makers noted that Aflibercept 8mg is clinically equivalent and of at least equal cost-effectiveness to the NICE recommended aflibercept 2mg formulation (TA 346 and TA294).

Formycon receives EU approval for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand names AHZANTIVE® and Baiama® 20.01.2025 / 06:30 CET/CEST The issuer is solely responsible for the ...

The drug is a “first-in-class” protein-based compound that combines different ... switching to sozinibercept in combination with aflibercept was well tolerated with improved visual and ...